CFD RESEARCH CORPORATION — Department of Defense STTR Phase II: CFD DHA MEDICAL RESEARCH CONTRACT FOR, MULTIPLEXED MULTI-OMICS BIOMARKER PANEL FROM MINIMA
CFD RESEARCH CORPORATION — STTR Phase II award from Department of Defense.
Phase II STTR prototype / development signal
- Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- Obligated amount $1,299,969 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
- Tagged technology areas: Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
CFD Research Corporation received a $1.3 million STTR Phase II award from the Defense Health Agency. The project develops a multiplexed multi-omics biomarker panel from minimally invasive samples for medical research.
- Amount
- $1,299,969
- Agency
- Department of Defense · Defense Health Agency
- Program / Phase
- STTR · Phase II
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- AL
- Period
- 2024-09-20 → 2027-01-19
Technology domains
Description
CFD DHA STTR PHASE II MEDICAL RESEARCH CONTRACT FOR, MULTIPLEXED MULTI-OMICS BIOMARKER PANEL FROM MINIMALLY INVASIVE BIOMATRIX, PROPOSAL NO. H2-0787.